Little Green Pharma returns to black
Little Green Pharma reports record revenue and a return to profits Botanix raises $48 million of debt for its anti-sweating drug, Sofdra The DNA of Genetic Technologies soon will be … financial advice Little Green Pharma's (ASX:LGP) European foray is …